Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
Umekawa T, Maki S, Kubo M, Tanaka H, Nii M, Tanaka K, Osato K, Kamimoto Y, Tamaru S, Ogura T, Nishimura Y, Kodera M, Minamide C, Nishikawa M, Endoh M, Kimura T, Kotani T, Nakamura M, Sekizawa A, Ikeda T; TADAFER study group. Umekawa T, et al. Among authors: kodera m. BMJ Open. 2018 Oct 30;8(10):e020948. doi: 10.1136/bmjopen-2017-020948. BMJ Open. 2018. PMID: 30381311 Free PMC article.
Successful renal transplantation for a patient with pyoderma gangrenosum.
Fujita T, Kinukawa T, Hattori R, Suzuki A, Ishida S, Kimura T, Kato M, Tsuji Y, Kodera M, Mihara K. Fujita T, et al. Among authors: kodera m. Transplant Proc. 2009 Jan-Feb;41(1):437-40. doi: 10.1016/j.transproceed.2008.10.061. Transplant Proc. 2009. PMID: 19249575
Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition.
Ito T, Kukino R, Sarayama Y, Tanioka M, Maekawa T, Yatsushiro H, Asai J, Asano Y, Abe M, Amano M, Ikegami R, Ishii T, Isei T, Isogai Z, Inoue Y, Irisawa R, Iwata Y, Otsuka M, Omoto Y, Kato H, Tanizaki H, Kadono T, Kaneko S, Kanoh H, Kawakami T, Kawaguchi M, Kono T, Koga M, Kodera M, Sakai K, Sakurai E, Shintani Y, Tsujita J, Doi N, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Hirosaki K, Fujita H, Fujimoto M, Fujiwara H, Matsuo K, Madokoro N, Motegi SI, Yamasaki O, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H. Ito T, et al. Among authors: kodera m. J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17503. Online ahead of print. J Dermatol. 2024. PMID: 39723550
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
149 results